Search results for "DRUG DISCOVERY"

showing 10 items of 3927 documents

Determination of butyl methoxydibenzoylmethane, benzophenone-3, octyl dimethyl PABA and octyl methoxycinnamate in lipsticks.

2003

The complex composition of lipstick formulations usually needs the use of organic solvents for sample dissolution. A treatment based on dissolution of cosmetic samples in ethanol-water (70 : 30, v/v) by use of ultrasonic irradiation is proposed. A C(18) stationary phase and an isocratic mobile phase of ethanol:water:acetic acid (70 : 29.5 : 0.5, v/v/v) with a flow rate of 1 mL min(-1) and an injection volume of 20 microL is proposed for the high-pressure liquid chromatography (HPLC) determination of four UV-filters, and detection was carried out at 309 nm. The limit of the chromatographic detection was 7.0 microg mL(-1) for butyl methoxydibenzoylmethane, 1.5 microg mL(-1) for benzophenone-3…

AgingChromatographyEthanolPharmaceutical ScienceOctyl methoxycinnamateDermatologyLipstickHigh-performance liquid chromatographyAcetic acidchemistry.chemical_compoundColloid and Surface ChemistrychemistryChemistry (miscellaneous)Drug DiscoveryBenzophenoneOxybenzoneTetrahydrofuranInternational journal of cosmetic science
researchProduct

Aging and neuroinflammatory disorders: New biomarkers and therapeutic targets

2019

: Chronic neuroinflammation is a common feature of the pathogenic mechanisms involved in various neurodegenerative age-associated disorders, such as Alzheimer's disease, multiple sclerosis, Parkinson’s disease, and dementia. : In particular, persistent low-grade inflammation may disrupt the brain endothelial barrier and cause a significant increase of pro-inflammatory cytokines and immune cells into the cerebral tissue that, in turn, leads to microglia dysfunction and loss of neuroprotective properties. : Nowadays, growing evidence highlights a strong association between persistent peripheral inflammation, as well as metabolic alterations, and neurodegenerative disorder susceptibility. The…

AgingInflammationDiseaseNeurodegenerative diseaseNeuroprotection03 medical and health sciences0302 clinical medicineImmune systemDrug DiscoverymedicineDementiaHumansTherapeutic targetsNeuroinflammation030304 developmental biologyPharmacologyInflammation0303 health sciencesMicrogliabusiness.industryMultiple sclerosisNeurodegenerative DiseasesBiomarkermedicine.diseasemedicine.anatomical_structureMicrogliamedicine.symptombusinessNeuroscienceNeuroinflammatory030217 neurology & neurosurgeryBiomarkers
researchProduct

Antioxidants as a Potential Therapy Against Age-Related Neurodegenerative Diseases: Amyloid Beta Toxicity and Alzheimers Disease

2006

Alzheimer's disease (AD) is a progressive age-related neurodegenerative disorder with distinct neuropathological features. Extracellular plaques, consisting of aggregated amyloid peptides of 39-43 amino acids are one of the most prominent pathological hallmarks of this disease. Although the exact neurochemical effector mechanism of Abeta aggregation is not yet elucidated, age-associated disturbances of metal ion metabolism have been proposed to promote the formation of aggregates from soluble Abeta. Oxidative stress is postulated to be a downstream effect of Abeta-metal ion interactions. Therefore, the modulation of brain metal metabolism and attenuation of oxidative stress by antioxidant m…

Agingmedicine.medical_specialtyAntioxidantAmyloidAmyloid betamedicine.medical_treatmentPharmacologymedicine.disease_causeAntioxidantsNeurochemicalDegenerative diseaseAlzheimer DiseaseInternal medicinemental disordersDrug DiscoverymedicineAnimalsHumansPharmacologyAmyloid beta-PeptidesMetal metabolismbiologyChemistryNeurodegenerative Diseasesmedicine.diseaseEndocrinologybiology.proteinAlzheimer's diseaseOxidative stressCurrent Pharmaceutical Design
researchProduct

Synthesis and Characterization of a Novel Series of Agonist Compounds as Potential Radiopharmaceuticals for Imaging Dopamine D-2/3 Receptors in Their…

2014

Imaging of dopamine D2/3 receptors (D2/3R) can shed light on the nature of several neuropsychiatric disorders in which dysregulation of D2/3R signaling is involved. Agonist D2/3 tracers for PET/SPECT imaging are considered to be superior to antagonists because they are more sensitive to dopamine concentrations and may selectively label the high-affinity receptor state. Carbon-11-labeled D2/3R agonists have been developed, but these short-lived tracers can be used only in centers with a cyclotron. Here, we report the development of a series of novel D2R agonist compounds based on the 2-aminomethylchromane (AMC) scaffold that provides ample opportunities for the introduction of longer-lived […

AgonistD-3 RECEPTORPHARMACOPHOREChemistrymedicine.drug_classDERIVATIVESPharmacologyIN-VIVO ACTIVITYHUMAN BRAINRadioligand AssayANTERIOR-PITUITARYPOSITRON-EMISSION-TOMOGRAPHYENDOGENOUS DOPAMINEIn vivoDopamineSpect imagingDopamine receptor D2Drug DiscoveryLIGAND-BINDINGmedicineMolecular MedicineReceptorAGENTSEndogenous agonistmedicine.drugJournal of Medicinal Chemistry
researchProduct

Histaprodifens: synthesis, pharmacological in vitro evaluation, and molecular modeling of a new class of highly active and selective histamine H(1)-r…

2000

A new class of histamine analogues characterized by a 3, 3-diphenylpropyl substituent at the 2-position of the imidazole nucleus has been prepared outgoing from 4,4-diphenylbutyronitrile (4b) via cyclization of the corresponding methyl imidate 5b with 2-oxo-4-phthalimido-1-butyl acetate or 2-oxo-1,4-butandiol in liquid ammonia, followed by standard reactions. The title compounds displayed partial agonism on contractile H(1) receptors of the guinea-pig ileum and endothelium-denuded aorta, respectively, except 10 (histaprodifen; 2-[2-(3, 3-diphenylpropyl)-1H-imidazol-4-yl]ethanamine) which was a full agonist in the ileum assay. While 10 was equipotent with histamine (1), methylhistaprodifen (…

AgonistMaleModels MolecularRhodopsinRanidaeStereochemistrymedicine.drug_classGuinea PigsSubstituentIleumHistamine H1 receptorIn Vitro TechniquesChemical synthesis/dk/atira/pure/sustainabledevelopmentgoals/clean_water_and_sanitationHistamine Agonistschemistry.chemical_compoundStructure-Activity RelationshipIleumDrug DiscoverymedicineImidazoleAnimalsHumansVasoconstrictor AgentsReceptors Histamine H1Rats WistarAortaChemistryMethylhistaminesMuscle SmoothIn vitroProtein Structure TertiaryRatsReceptors Neurotransmittermedicine.anatomical_structureMolecular MedicineEndothelium VascularSDG 6 - Clean Water and SanitationHistamineMuscle ContractionJournal of medicinal chemistry
researchProduct

Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possible relationship to the effe…

2004

<i>Background:</i> The effects of the A<sub>3</sub> adenosine receptor (A<sub>3</sub>AR) agonist IB-MECA were examined in HL-60 leukemia and in its multidrug-resistant variant HL-60R cells. <i>Methods:</i> Cytotoxicity was evaluated by MTS assays and apoptosis by flow cytometry analyses of DNA fragmentation and phosphatidylserine exposure. The mRNAs of A<sub>3</sub>AR and inhibitor of apoptosis proteins (IAPs) were determined by RT-PCR. <i>Results:</i> A<sub>3</sub>AR expression was similar in HL-60 and HL-60R cells. At ≧100 µ<i>M</i>, IB-MECA exhibited strong cytotoxic and apoptotic effects in H…

AgonistProgrammed cell deathAdenosinemedicine.drug_classApoptosisHL-60 CellsBiologyInhibitor of apoptosisInhibitor of Apoptosis ProteinsDrug DiscoverymedicineNeoplasmHumansPharmacology (medical)PharmacologyGeneral Medicinemedicine.diseaseAdenosine A3 receptorFlow CytometryAdenosineDrug Resistance MultipleLeukemiaInfectious DiseasesOncologyBiochemistryApoptosisDrug Resistance NeoplasmA 3 adenosine receptor IB-MECA Apoptosis Multidrug resistance Inhibitor of apoptosis proteinsCancer researchmedicine.drugChemotherapy
researchProduct

Synthesis of 2-Prenylated Alkoxylated Benzopyrans by Horner–Wadsworth–Emmons Olefination with PPARα/γ Agonist Activity

2021

[Image: see text] We have synthesized series of 2-prenylated benzopyrans as analogues of the natural polycerasoidol, a dual PPARα/γ agonist with anti-inflammatory effects. The prenylated side chain consists of five or nine carbons with an α-alkoxy-α,β-unsaturated ester moiety. Prenylation was introduced via the Grignard reaction, followed by Johnson–Claisen rearrangement, and the α-alkoxy-α,β-unsaturated ester moiety was introduced by the Horner–Wadsworth–Emmons reaction. Synthetic derivatives showed high efficacy to activate both hPPARα and hPPARγ as dual PPARα/γ agonists. These prenylated benzopyrans emerge as lead compounds potentially useful for preventing cardiometabolic diseases.

AgonistSynthetic derivatives[CHIM.ORGA]Chemical Sciences/Organic chemistry010405 organic chemistrymedicine.drug_classStereochemistryOrganic ChemistryHorner–Wadsworth–Emmons reactionGrignard reaction01 natural sciencesBiochemistry0104 chemical sciences3. Good health010404 medicinal & biomolecular chemistrychemistry.chemical_compoundchemistryPrenylationDrug DiscoverySide chainmedicinePPARα/γ activityMoietyPrenylated benzopyransHorner-Wadsworth-Emmons reactionBenzopyransACS Medicinal Chemistry Letters
researchProduct

Synthesis and pharmacological characterization of beta2-adrenergic agonist enantiomers: zilpaterol.

2009

The beta-adrenergic agonist 1 (zilpaterol) is used as production enhancer in cattle. Binding experiments of separated enantiomers on recombinant human beta(2)-adrenergic and mu-opioid receptors and functional studies showed that the (-)-1 enantiomer accounts for essentially all the beta(2)-adrenergic agonist activity and that it exhibits less affinity toward the mu-opioid receptor than (+)-1, which is a mu-opioid receptor antagonist. X-ray crystallography revealed the absolute configuration of (-)-1 to be 6R,7R.

AgonistTrimethylsilyl CompoundsStereochemistrymedicine.drug_classZilpaterolAbsolute configurationBiological activityStereoisomerismPharmacologyAdrenergic beta-AgonistsReceptor antagonistCrystallography X-RayRecombinant Proteinschemistry.chemical_compoundchemistryDrug DiscoverymedicineMolecular MedicineHumansEnantiomerReceptorBeta (finance)Adrenergic beta-2 Receptor AgonistsChromatography High Pressure LiquidJournal of medicinal chemistry
researchProduct

Synthetic studies of neoclerodane diterpenoids from Salvia splendens and evaluation of opioid receptor affinity

2008

Abstract Salvinorin A ( 1 ), a neoclerodane diterpene from the hallucinogenic mint Salvia divinorum , is the only known non-nitrogenous and specific κ-opioid agonist. Several structural congeners of 1 isolated from Salvia splendens ( 2 – 8 ) together with a series of semisynthetic derivatives ( 9 – 24 ), some of which possess a pyrazoline structural moiety ( 9 , 19 – 22 ), have been tested for affinity at human μ, δ, and κ opioid receptors. None of these compounds showed high affinity binding to these receptors. However, 10 showed modest affinity for κ receptors suggesting that other natural neoclerodanes from different Salvia species may possess opioid affinity.

AgonistbiologyChemistrymedicine.drug_classStereochemistryOrganic ChemistryPyrazolineSalviabiology.organism_classificationBiochemistryArticleSalvinorin Achemistry.chemical_compoundOpioid receptorClerodanes opioid receptors salviaDrug DiscoverySalvia divinorummedicineDiterpeneReceptor
researchProduct

Darstellung und H2-agonistische Aktivität alkylsubstituierter 3-(Imidazol-4-yl)propylguanidine Synthesis and H2-Agonistic Activity of Alkyl-3-(imidaz…

1987

Derivate des 3-(Imidazol-4-yl)propylguanidins mit einem Methyl- oder einem 2-(Ethylthio)ethyl-Substituenten2) an der Guanidin-Gruppe weisen am H2-Rezeptor des Meerschweinchenvorhofs nur 10–20% der Histaminaktivitat auf. Dagegen fuhrt die Substitution mit der H2-affinen 2-[(5-Methylimidazol-4-yl) methylthio]ethyl-Gruppierung zu Impromidin, einem hochpotenten H2-Agonisten.

Agonistchemistry.chemical_classificationPropylguanidinemedicine.drug_classStereochemistryPharmaceutical SciencePropylamineBiological activityAmidinechemistry.chemical_compoundEthanolaminechemistryDrug DiscoverymedicineImidazoleAlkylArchiv der Pharmazie
researchProduct